Varian Medical Systems has made a new investment in Bend It Technologies, an Israel-based company that is developing steerable microcatheters.
Bend It’s microcatheters are used by interventionalists for minimally invasive peripheral vascular procedures.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataVarian is investing in Bend It’s Series B funding round and a representative of the company will join the latter’s board of directors.
As compared with open surgery, interventional procedures require the injection of diagnostic or therapeutic materials into a targeted area of the body through blood vessels. The microcatheters can be used for delivering diagnostic, embolic or therapeutical materials into the vasculature.
Varian Interventional Solutions business president Francis Facchini said: “The Bend It catheters’ unique design brings 3D steerability to a new dimension in microcatheter technologies, providing interventional radiologists with control of the catheter tip and tip shape to successfully navigate even the most tortuous anatomy.
“This optimises ‘guidewire-less’ navigation for delivery of embolic therapies.
“We believe the Bend It steerable microcatheter has the potential to enhance patient safety, reduce procedure time and produce better outcomes.”
Bend It’s patented technology is FDA 510(k) cleared and CE marked. It offers 3D-controlled bending and navigation capabilities that help doctors provide rapid and precise treatment by placing catheters through blood vessels that are otherwise difficult to traverse.
Furthermore, the Bend It peripheral use microcatheter allows doctors to navigate into the body through the radial artery in the wrist, as well as the more traditional femoral artery in the groin, which can lower patient risk for some procedures.
Bend It CEO Yossi Mazel said: “We are thrilled to have Varian invest in Bend It Technologies and join its board of directors.
“There is no doubt that Varian’s strong market presence will impact Bend It significantly as the company grows its product portfolio and gets ready to commercially launch its steerable catheters.”
